全文获取类型
收费全文 | 4608篇 |
免费 | 351篇 |
国内免费 | 211篇 |
学科分类
医药卫生 | 5170篇 |
出版年
2024年 | 6篇 |
2023年 | 57篇 |
2022年 | 157篇 |
2021年 | 165篇 |
2020年 | 124篇 |
2019年 | 126篇 |
2018年 | 109篇 |
2017年 | 137篇 |
2016年 | 144篇 |
2015年 | 140篇 |
2014年 | 234篇 |
2013年 | 254篇 |
2012年 | 194篇 |
2011年 | 299篇 |
2010年 | 298篇 |
2009年 | 305篇 |
2008年 | 294篇 |
2007年 | 297篇 |
2006年 | 306篇 |
2005年 | 227篇 |
2004年 | 267篇 |
2003年 | 215篇 |
2002年 | 197篇 |
2001年 | 121篇 |
2000年 | 79篇 |
1999年 | 73篇 |
1998年 | 42篇 |
1997年 | 24篇 |
1996年 | 27篇 |
1995年 | 34篇 |
1994年 | 29篇 |
1993年 | 17篇 |
1992年 | 12篇 |
1991年 | 10篇 |
1990年 | 9篇 |
1989年 | 8篇 |
1988年 | 4篇 |
1987年 | 5篇 |
1986年 | 8篇 |
1985年 | 13篇 |
1984年 | 27篇 |
1983年 | 10篇 |
1982年 | 14篇 |
1981年 | 8篇 |
1980年 | 10篇 |
1979年 | 8篇 |
1978年 | 4篇 |
1977年 | 7篇 |
1976年 | 5篇 |
1972年 | 3篇 |
排序方式: 共有5170条查询结果,搜索用时 15 毫秒
1.
2.
Abstract: We describe the use of restriction analysis on PCR-amplified DNA for detecting all B*27 subtypes except B*2710 and B*2711 (i.e. from B*2701 to B*2709). After detecting B*27 by Sty I, double digestions consisting of Sty I plus another informative enzyme led to subtype assignment. We used mismatched primers to create restriction sites when necessary. The method avoids group-specific amplifications and other laborious optimization procedures. It was successfully tested on a panel of well characterized cell lines covering different B*27 subtypes. Then, we studied a group of 57 ankylosing spondyiitis patients and 746 controls from the south of Spain. B*27 showed a very strong association with the disease (OR=211.27, P=\0˜7). B*2702 and B*2705 distribution in controls (20% and 77.1%, respectively) differed from previously reported data in the Spanish population. We unexpectedly found the B*2707 allele in our population (one control). 相似文献
3.
4.
目的 :应用SSP PCR(Sequencespecialprime polymerasechainreaction)基因检定技术对急性前葡萄膜炎 (a cuteanterioruveitis ,AAU)患者HLA B2 7基因进行检测 ,并且对HLA B2 7阳性与阴性患者临床特征加以分析。方法 :采用SSP PCR基因检定技术检测 98例AAU患者及 82例正常人样本的HLA B2 7基因。并对HLA B2 7阳性与阴性患者临床特征进行观察。结果 :98例AAU患者样本中有 5 7例样本呈HLA B2 7阳性 ,82例正常人样本有 4例样本呈HLA B2 7阳性 ,阳性率分别为 5 8.2 %和 4 .9%。经 χ2 检验 ,χ2 =4 1.33,P <0 .0 0 5 ,二组间有显著差异。HLA B2 7阳性患者多见于男性 ,单眼多见 ,粉尘状KP ,发病时视力下降明显 ,易于复发 ,且并发症少为其特征 ,激素治疗效果佳。结论 :采用SSP PCR基因检定技术测定HLA B2 7快速、简单、准确性高、客观性强 ,值得推广和应用。HLA B2 7与急性前葡萄膜炎有着高度相关性。HLA B2 7阳性患者与阴性患者在临床特征上有着一定程度的差异。 相似文献
5.
Expression of p27 and p53: comparative analysis of uterine carcinosarcoma and endometrial carcinoma 总被引:1,自引:0,他引:1
A. Abargel I. Avinoach† V. Kravtsov† M. Boaz‡ M. Glezerman‡ & J. Menczer‡ 《International journal of gynecological cancer》2004,14(2):354-359
The aim of the study was to assess both p27 and p53 expression in the stromal and epithelial component of carcinosarcoma and to assess if their expression in the latter is different than in endometrial carcinoma. Immunohistochemical staining for p27 and p53 was performed on paraffin-embedded tissue blocks of 18 uterine specimens with carcinosarcoma and their expression assessed. Their expression in the epithelial element was also compared to that in 35 paraffin-embedded tissue blocks of endometrial endometrioid carcinoma. Reduced p27 expression was observed in a similarly high proportion of the stromal (77.8%) as well as of the epithelial component (66.7%) of carcinosarcoma. Although statistically not significant, the proportion of reduced p27 expression in endometrial carcinoma (85.7%) was higher than in the epithelial element of carcinosarcoma. The percentage of p53 overexpression in both elements of carcinosarcomas and in endometrial carcinomas was low and also similar (27.8 and 20.0%, respectively). Our results indicate that reduced p27 expression is common and p53 overexpression is infrequent in carcinosarcoma. Their similar rates of expression in the stromal and epithelial elements of the tumor support the contention of a monoclonal origin of carcinosarcoma. Unexpectedly, reduced p27 expression is more common in endometrial carcinoma than in the epithelial element of carcinosarcoma, in spite of the less favorable prognosticators and outcome in the latter. Further studies of p27 expression in carcinosarcoma are indicated to establish its clinical value in this aggressive malignancy. 相似文献
6.
A. V. Filatov S. A. Prokof'ev V. V. Shcherbukhin 《Bulletin of experimental biology and medicine》1992,114(5):1656-1659
Institute of Immunology, Ministry of Health of Russian. (Presented by Academician of the Russian Academy of Medical Sciences R. V. Petrov.) Translated from Byulleten Éksperimental'noi Biologii i Meditsiny, Vol. 114, No. 11, pp. 506–508, November, 1992. 相似文献
7.
K. Iwatsuki F. Yamagishi S. Chiba 《Clinical and experimental pharmacology & physiology》1986,13(6):487-494
The effects of a synthesized phosphodiesterase inhibitor, ZSY-27, on the secretion of pancreatic juice were investigated in dog isolated and blood-perfused pancreas, and compared with those of secretin and dopamine. Intravenous administration of ZSY-27 (0.3-1 mg/kg) elicited increases in pancreatic secretion. Intra-arterial (i.a.) administration of ZSY-27 (0.1-1 mg) also elicited increased secretion. The secretory activity of ZSY-27 (1 mg) was approximately equal to that of 0.1 units of secretin and 2.5 micrograms of dopamine. The concentration of bicarbonate in the pancreatic juice induced by ZSY-27 i.a. was increased, but the protein concentration was not increased significantly. These effects are analogous to those of secretin and dopamine. ZSY-27-induced pancreatic secretion was not modified by pretreatment with phentolamine, propranolol, atropine, sulpiride and cimetidine. Secretin-induced secretion was significantly potentiated by infusion of ZSY-27 (25 micrograms/min) but dopamine-induced one was not. These results suggest that ZSY-27 increases pancreatic secretion acting directly on the ductular cells of the dog pancreas, at least in part, through the increase of intracellular cyclic AMP concentration by inhibiting phosphodiesterase activity. 相似文献
9.
背景与目的:探讨莱菔硫烷对人膀胱癌细胞(T24)细胞周期的影响及作用机制。材料与方法:采用噻唑蓝(MTT)法研究不同浓度的莱菔硫烷对T24细胞生长的抑制作用并测定其半数抑制浓度(IC50);采用流式细胞仪检测莱菔硫烷对T24细胞周期的影响;采用westernblot研究莱菔硫烷对T24细胞中细胞周期蛋白依赖激酶抑制剂P16和P27的表达情况。结果:在较低剂量范围内(≤40μmol/L),随着作用剂量的增加,莱菔硫烷对T24细胞的生长的抑制作用也明显增强。10、20、40μmol/L莱菔硫烷的抑制率分别为(12.5±3.95)%,(25.0±2.50)%、(50.0±5.33)%;在较高剂量(60μmol/L~160μmol/L)时,这种抑制作用不再呈剂量依赖性;莱菔硫烷作用72h后的IC50值为(51.12±7.10)μmol/L;莱菔硫烷能使T24细胞周期阻滞于G0/G1期,20μmol/L莱菔硫烷作用48h后,在G0/G1峰之前出现凋亡峰;20μmol/L莱菔硫烷作用于T24细胞8、12、24h后能明显诱导P27蛋白的表达,作用早期(8h)时能诱导P16蛋白的表达。结论:莱菔硫烷能抑制T24细胞生长并使该细胞周期阻断在G0/G1期,其作用机制主要是通过诱导P27蛋白及早期诱导P16蛋白来实现的。 相似文献
10.
目的 :研究cyclinD1 bcl 1和p2 7 kip1在脑胶质瘤中表达及其与病理分级和患者预后的关系。方法 :用免疫法组化技术对 4 8例不同恶性程度 (WHO分类法 )的脑胶质瘤组织和 12例非肿瘤组织中cyclinD1 bc1 1和p2 7 kip1蛋白的表达作了检测 ,用图像分析系统定量分析 ,并与临床资料紧密相联系进行统计学处理。结果 :两种蛋白的免疫反应复合物定位于细胞核。其在脑胶质瘤中的阳性表达都高于非肿瘤组织 (P <0 0 5 ) ,cyclinD1 bcl 1阳性颜色的数量和强度都随肿瘤的恶性程度升高而增加 (P <0 0 5 ) ,相反p2 7 kip1阳性染色的数量和强度都随肿瘤的恶性程度升高而降低 (P <0 0 5 )。cyclinD1 bcl 1的高表达或 和p2 7 kip1的低表达预示着预后差。结论 :CyclinD1 bcl 1和p2 7 kip1的异常表达可能与脑胶质瘤的发生发展密切相关 ,二者可能有协同作用。二者的表达都可作为判断预后的一个指标 相似文献